Pursuant to Reg 30 & 47 read with Schedule III of SEBI (LODR) Regulations, 2015, please find enclosed a copy of newspaper publication in the following newspaper with respect to Audited ....
Awaiting price reaction for this filing.
Jupiter Life Line Hospitals has published its audited Q4 and FY25 financial results in Financial Express and Pudhari (Marathi) newspapers, as required under SEBI listing rules. On a standalone basis, full-year revenue grew about 16% year-on-year to Rs 1,060 crore, while net profit rose roughly 22% to Rs 184.7 crore, with EPS at Rs 28.17 vs Rs 24.68 last year. On a consolidated basis, FY25 revenue increased around 17.5% to Rs 1,261.5 crore and net profit came in at Rs 193.5 crore (vs Rs 176.6 crore in FY24), translating to EPS of Rs 29.47. For Q4 standalone, revenue was Rs 273.9 crore and net profit Rs 44.4 crore, slightly higher than the Rs 246.1 crore and Rs 43.1 crore reported in Q4 FY24. The Board has recommended a final dividend of Re 1 per equity share for FY25.
The filing itself is a routine newspaper publication, but it highlights decent top-line growth and a modest dividend for shareholders, broadly a neutral-to-positive signal for the stock.